Reasons Vary Why People Want to “Wait and See” Before Getting a COVID-19 Vaccine. February 12, 2021 News Release Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations. The latest analysis from the KFF COVID-19 Vaccine Monitor highlights how attitudes differ by…
KFF COVID-19 Vaccine Monitor: What Do We Know About Those Who Want to “Wait and See” Before Getting a COVID-19 Vaccine? February 12, 2021 Poll Finding Thirty-one percent of the public wants to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. While they share a similar level of vaccine hesitancy, this group is not monolithic in their attitudes and beliefs. This brief examines how people with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and may respond differently to messages and information.
KFF COVID-19 Vaccine Monitor: In Their Own Words February 8, 2021 Poll Finding This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,
In Their Own Words: What People are Saying about Getting a COVID-19 Vaccine February 8, 2021 News Release As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side effects, including allergic reactions and long-term consequences, are the public’s top concern about getting vaccinated when asked to describe what worries them in their own words. The latest report from…
Public Perspectives on Women’s Health Policy Priorities for the Biden-Harris Administration and Congress February 2, 2021 Issue Brief The KFF Women’s Health Survey asked respondents how much of a priority seven key women’s health policies should be for the new President and Congress. This issue brief examines attitudes toward those policy priorities and differences by gender, political party affiliation, and demographic factors.
Most Hispanic Adults Lean Towards Getting a COVID-19 Vaccine, But Many Younger Adults are Hesitant January 14, 2021 News Release A new analysis of KFF COVID-19 Vaccine Monitor survey data finds that most Hispanic adults across the country want to get a COVID-19 vaccine at some point though younger adults are more hesitant, in part because of lower confidence that it is safe and effective. Overall a quarter (26%) of…
Vaccine Hesitancy Among Hispanic Adults January 14, 2021 Poll Finding Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among Hispanic Americans toward the coronavirus and a generational gap in willingness to get a potential vaccine.
Analysis: Rural Residents Stand Out as One of the Most Hesitant Groups to Get a COVID-19 Vaccine and Pose Special Challenges for the Mass Vaccination Efforts January 7, 2021 News Release A new analysis of KFF COVID-19 Vaccine Monitor survey data finds that residents of rural America stand out as one of the groups most hesitant to get a COVID-19 vaccine and that their views about the pandemic could pose significant challenges for the nation’s mass vaccination effort. About a third…
Vaccine Hesitancy in Rural America January 7, 2021 Poll Finding Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among rural Americans toward the coronavirus and willingness to get a potential vaccine.
KFF Launches New COVID-19 Vaccine Monitor to Track the Public’s Confidence in the Vaccine and Experiences for the Duration of the Pandemic December 15, 2020 News Release Republicans and Black Americans are More Likely to Be Hesitant but Even Among These Groups Reasons Vary KFF has launched a new COVID-19 Vaccine Monitor to dive deeply into the public’s views about the vaccine and experiences getting it for as long as the pandemic lasts. First results released today…